That’s according to an AdvaMed spokesman, who couldn’t yet say when McEvoy would step down or whether anyone has been tapped to serve the rest of her term. The medtech industry group expects to make an announcement soon, he said.
AdvaMed’s board of directors unanimously elected McEvoy to a two-year term as chair in March.
She announced her resignation from J&J “to pursue new opportunities” yesterday, but did not say whether she plans to stay in the medical device industry.
Medical Design & Outsourcing: Ashley McEvoy joins J&J’s top-paid executives
McEvoy will remain with J&J into 2024. The company — the world’s second-largest medical device manufacturer — has named Tim Schmid as her replacement.
“I’ve appreciated Ashley’s steady leadership and vision for AdvaMed and our entire industry for more than five years as an active, thoughtful member of our board and as our chair,” AdvaMed President and CEO of AdvaMed Whitaker said in a statement emailed to MassDevice. “She is an exceptional leader. I know I speak for everyone on the Board and the entire AdvaMed team when I say we will miss working alongside her, but we look forward to her next chapter, which I know will be exciting and impactful.”
